Macquarie lowered the firm’s price target on Braze (BRZE) to $35 from $40 and keeps a Neutral rating on the shares. Braze’s top line beat by 2%, but profitability was lower as a result of its recent OfferFit acquisition, while its dollar-based net retention fell to 109%, with continued excess churn impacting reaccelerated revenue growth, the analyst tells investors in a research note. The firm remains on the sidelines with the stock well priced.

Confident Investing Starts Here:

• Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions

• Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on BRZE:

Disclaimer & DisclosureReport an Issue

• Braze price target lowered to $43 from $47 at TD Cowen

• Braze price target lowered to $45 from $47 at JPMorgan

• Braze price target lowered to $45 from $75 at Loop Capital

• Braze price target lowered at Raymond James, says pullback a buying opportunity

• Braze price target lowered to $40 from $45 at Stifel